Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2003 | |
| Sales | 8,260 |
| Gross Profit | 8,260 |
| Operating Expenses | 27,462 |
| Operating Income | -19,202 |
| Interest Expense | 521 |
| Other Income | 718 |
| Pre-tax Income | -19,005 |
| Net Income Continuous | -19,005 |
| Net Income | $-19,005 |
| EPS Basic Total Ops | -20,354.47 |
| EPS Basic Continuous Ops | -20,355.54 |
| EPS Diluted Total Ops | -20,354.47 |
| EPS Diluted Continuous Ops | -20,355.54 |
| EBITDA(a) | $-16,572 |